C-type natriuretic peptide regulation of guanosine-3′,5′-cyclic monophosphate production in human endothelial cells

Autonomic and Autacoid Pharmacology

Volumn 30, Issue 3, 2010, Pages 185-192

  Rautureau, Y ^a   Gowers, I ^a   Wheeler Jones, C P D ^a   Baxter, G F ^a,b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Endothelium; Guanosine 3 ,5 Cyclic monophosphate; Natriuretic peptides; Particulate guanylyl cyclase; Phosphodiesterases

Indexed keywords

AUTACOID; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLYL CYCLASE A; GUANYLYL CYCLASE B; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

1-METHYL-3-ISOBUTYLXANTHINE; CELLS, CULTURED; CYCLIC GMP; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GENE EXPRESSION; GUANYLATE CYCLASE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDE, C-TYPE; NITRIC OXIDE; NITROPRUSSIDE; OXADIAZOLES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; QUINOXALINES; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, CELL SURFACE; UMBILICAL CORD;

EID: 77953505042     PISSN: 14748665     EISSN: 14748673     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2009.00449.x     Document Type: Article

References (40)

1. ABBEY, S.E POTTER, L.R (2003). Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B. Endocrinology, 144, 240 246.
2. AHLUWALIA, A. HOBBS, A.J. (2005). Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factor. Trends Pharmacol. Sci., 26, 162 167.
3. AIRHART, N., YANG, Y.F., ROBERTS, C.T., JR. SILBERBACH, M. (2003). Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction. J. Biol. Chem., 278, 33693 33698.
4. BALDINI, P.M., DE VITO, P., MARTINO, A., FRAZIANO, M., GRIMALDI, C., LULY, P., ZALFA, F. COLIZZI, V. (2003). Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement. J. Leucocyte Biol., 73, 502 510.
5. BAXTER, G.F. (2004). The natriuretic peptides: an introduction. Basic Res. Cardiol., 99, 71 75.
6. BROWN, J. CHEN, Q. (1995). Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit. Circ. Res., 77, 906 918.
7. BRUNNER, F. WOLKART, G. (2001a). Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Cardiovasc. Res., 51, 577 584.
8. BRUNNER, F. WOLKART, G. (2001b). Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Microvasc. Res., 61, 102 110.
9. BURLEY, D.S., FERDINANDY, P. BAXTER, G.F. (2007). Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signalinh. Br. J. Pharmacol., 152, 855 869.
10. CHAUHAN, S.D., NILSSON, H., AHLUWALIA, A. HOBBS, A.J. (2003a). Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc. Natl Acad. Sci. USA, 100, 1426 1431.
11. CHAUHAN, S.D., SEGGARA, G., VO, P.A., MACALLISTER, R.J., HOBBS, A.J. AHLUWALIA, A. (2003b). Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J., 17, 773 775.
12. DEL RY, S., PASSINO, S., EMDIN, S. GIANNESSI, D. (2006). C-type natriuretic peptide and heart failure. Pharmacol. Res., 54, 326 333.
13. DOI, K., IKEDA, T., ITOH, H. et al. (2001). C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated re-endothelialization. Arterioscler. Thromb. Vasc. Biol., 21, 930 936.
14. GROSSER, N. SCHRODER, H. (2003). Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler. Throm. Vasc. Biol., 23, 1345 1351.
15. HAMAD, A.M., RANGE, S., HOLLAND, E. KNOX, A.J. (1997). Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Am. J. Physiol., 273, L807 L813.
16. HOUSLAY, M.D. MILLIGAN, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci., 22, 217 224.
17. HUSSAIN, M.B., MACALLISTER, R.J. HOBBS, A.J. (2001). Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. Am. J. Physiol., 280, H1151 H1159.
18. IGNARRO, L.J., WOOD, K.S., HARBISON, R.G. KADOWITZ, P.J. (1986). Atriopeptin II relaxes and elevates cGMP in bovine pulmonary artery but not vein. J. Appl. Physiol., 60, 1128 1133.
19. ITOH, H., PRATT, R.E., OHNO, M. DZAU, V.J. (1992). Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension, 19, 758 761.
20. KEOGH, R.J., HOULISTON, R.A. WHEELER-JONES, C.P. (2002). Thrombin-stimulated Pyk2 phosphorylation in human endothelium is dependent on intracellular calcium and independent of protein kinase C and Src kinases. Biochem. Biophys. Res. Commun., 294, 1001 1008.
21. KIEMER, A.K., WEBER, N.C., FURST, R., BILDNER, N., KULHANEK-HEINZE, S. VOLLMAR, A.M. (2002). Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ. Res., 90, 874 881.
22. KOOK, H., ITOH, H., CHOI, B.S., SAWADA, N., DOI, K., HWANG, T.J., KIM, K.K., ARAI, H., BAIK, Y.H. NAKAO, K. (2003). Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am. J. Physiol., 284, H1388 H1397.
23. 2+-ATPase in vascular endothelial cells. Life Sci., 73, 2019 2028.
24. LEURANGUER, V., VANHOUTTE, P.M., VERBEUREN, T. FELETOU, M. (2008). C-type natriuretic peptide and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. Br. J. Pharmacol., 153, 57 65.
25. MADHANI, M., SCOTLAND, R.S., MACALLISTER, R.J. HOBBS, A.J. (2003). Vascular natriuretic peptide receptor-linked particulate guanylyl cyclases are modulated by nitric oxide-cyclic GMP signalling. Br. J. Pharmacol., 139, 1289 1296.
26. MINERDS, K.L. DONALD, J.A. (2001). Natriuretic peptide receptors in the central vasculature of the toad, Bufo. Marinus. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 128, 259 268.
27. MORBIDELLI, L., CHANG, C.H., DOUGLAS, J.G., GRANGE, H.J., LEDD, F. ZICHE, M. (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol., 270, H411 H415.
28. NETHERTON, S.J. MAURICE, D.H. (2005). Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol. Pharmacol., 67, 263 272.
29. OHNO, N., ITOH, H., IKEDA, T. et al. (2002). Accelerated re-endothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation, 105, 1623 1626.
30. PADAYATTI, P.S., PATTANAIK, P., MA, X. VAN DEN AKKER, F. (2004). Structural insights into the regulation and the activation mechanism of mammalian guanylyl cyclases. Pharmacol. Ther., 104, 83 99.
31. PEDRAM, A., RAZANDI, M. LEVIN, E.R. (2002). Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J. Biol. Chem., 277, 44385 44398.
32. POTTER, L.R., ABBEY-HOSCH, S. DICKEY, D.M. (2006). Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev., 27, 47 72.
33. RIVERO-VILCHES, F.J., DE FRUTOS, S., SAURA, M., RODRIGUEZ-PUYOL, D. RODRIGUEZ-PUYOL, M. (2003). Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP. Am. J. Physiol., 285, C89 C98.
34. SIMON, A., HARRINGTON, E.O., LIU, G.X., KOREN, G. CHOUDHARY, G. (2009). Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolrization. Am. J. Physiol., 296, L248 L256.
35. SUENOBU, N., SHICHIRI, M., IWASHINA, M., MARUMO, F. HIRATA, Y. (1999). Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arterioscler. Thromb. Vasc. Biol., 19, 140 146.
36. TOLSA, J.F., GAO, Y., SANDER, F.C., SOUICI, A.C., MOESSINGER, A. RAJ, J.U. (2002). Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides. Am. J. Physiol., 282, H273 H280.
37. WEI, C.M., AARHUS, L.L., MILLER, V.M. BURNETT, J.C., JR. (1993). Action of C-type natriuretic peptide in isolated canine arteries and veins. Am. J. Physiol., 264, H71 H73.
38. WINQUIST, R.J., FAISON, E.P, WALDMAN, S.A., SCHWARTZ, K., MURAD, F. RAPOPORT, R.M. (1984). Atrial natriuretic factor elicits an endothelium- independent relaxation and activates particulate guanylyl cyclase in vascular smooth muscle. Proc. Natl Acad. Sci. USA, 81, 7661 7664.
39. WRIGHT, R.S., WEI, C.M., KIM, C.H., KINOSHITA, M., MATSUDA, Y., AARHUS, L.L., BURNETT, J.C., JR. MILLER, W.L. (1996). C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylyl cyclase systems. J. Am. Coll. Cardiol., 28, 1031 1038.
40. ZABEL, U., KLEINSCHNITZ, C., OH, P. et al. (2002). Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol., 4, 307 311. (Pubitemid 34308857)